scholarly article | Q13442814 |
P50 | author | Bertrand Dousset | Q50053335 |
P2093 | author name string | Olivier Scatton | |
Olivier Vignaux | |||
Bruto Randone | |||
Stéphane Zalinski | |||
P2860 | cites work | Hepatocellular carcinoma | Q29615841 |
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival | Q29616865 | ||
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver | Q29616866 | ||
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial | Q29617955 | ||
Prognostic prediction and treatment strategy in hepatocellular carcinoma. | Q34547469 | ||
Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients | Q34569671 | ||
Methods and related drawbacks in the estimation of surgical risks in cirrhotic patients undergoing hepatectomy. | Q34593215 | ||
Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. | Q34714683 | ||
A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma | Q34721838 | ||
Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients | Q35980414 | ||
Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma | Q40315298 | ||
Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma | Q40497024 | ||
IHPBA concordant classification of primary liver cancer: working group report. | Q40568444 | ||
Treatment of hepatocellular carcinoma in patients with cirrhosis | Q41640042 | ||
Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. | Q45091783 | ||
Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. | Q53558959 | ||
Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. | Q55067548 | ||
Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? | Q71183097 | ||
Hepatic resection for hepatocellular carcinoma. An audit of 343 patients | Q72158030 | ||
Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis | Q72636403 | ||
The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma | Q73338937 | ||
Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors | Q73857009 | ||
Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC | Q77059950 | ||
Immediate increase in arterial blood flow in embolized hepatic segments after portal vein embolization: CT demonstration | Q77378379 | ||
Long-term follow-up arterial chemoembolization combined with transportal ethanol injection used to treat hepatocellular carcinoma | Q77839497 | ||
P433 | issue | 44 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
P304 | page(s) | 6869-6872 | |
P577 | publication date | 2008-11-01 | |
P1433 | published in | World Journal of Gastroenterology | Q15708885 |
P1476 | title | Complete hepatocellular carcinoma necrosis following sequential porto-arterial embolization | |
P478 | volume | 14 |
Q86600718 | Necrosis of large hepatocellular carcinoma induced by preoperative portal vein embolization: a case report |
Q92954733 | Outcomes associated with the intention of loco-regional therapy prior to living donor liver transplantation for hepatocellular carcinoma |
Q44361669 | Significance of tumor necrosis for outcome of patients with hepatocellular carcinoma receiving locoregional therapy prior to liver transplantation |